NEW YORK (GenomeWeb) – N-of-One said today that it will provide clinical interpretation services to Intermountain Healthcare as part of the hospital system's oncology precision medicine services program.

Under the terms of the agreement, N-of-One will handle the interpretation of cancer patients' next-generation sequencing test results. Using its platform, the firm will link relevant biological and clinical knowledge to the mutation profiles of tumors and help oncologists identify more effective therapeutic strategies for their patients.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

The Associated Press reports that gene-edited food may soon be for sale.

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.